HOWARD W. ROBIN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

NEKTAR THERAPEUTICS

Filing Date Source Excerpt
2013-04-30 He received his B.S. in Accounting and Finance from Fairleigh Dickinson University in 1974.
2014-04-30 Mr. Robin served as Chief Executive Officer, President and a director of Sirna Therapeutics, Inc., a biotechnology company... He received his B.S. in Accounting and Finance from Fairleigh Dickinson University in 1974.
2016-04-29 He received his B.S. in Accounting and Finance from Fairleigh Dickinson University and serves as a member of its Board of Trustees.
2017-05-01 Howard W. Robin, age 64, has served as our President and Chief Executive Officer since January 2007 and has served as a member of our board of directors since February 2007. Mr. Robin served as Chief Executive Officer, President and a director of Sirna Therapeutics, Inc., a biotechnology company... He received his B.S. in Accounting and Finance from Fairleigh Dickinson University.
2018-04-30 Mr. Robin received his B.S. in Accounting and Finance from Fairleigh Dickinson University and serves as a member of its Board of Trustees.
2019-04-30 Mr. Robin received his B.S. in Accounting and Finance from Fairleigh Dickinson University and serves as a member of its Board of Trustees.
2020-04-29 He received his B.S. in Accounting and Finance from Fairleigh Dickinson University and serves as a member of its Board of Trustees.
2021-04-30 Mr. Robin has over 25 years of experience in the pharmaceutical and biotechnology industries in a variety of roles of increasing responsibility.
2022-04-29 He received his B.S. in Accounting and Finance from Fairleigh Dickinson University.
2023-04-28 He received his B.S. in Accounting and Finance from Fairleigh Dickinson University and serves as a member of its Board of Trustees.
2024-04-26 Howard W. Robin, age 71, has served as our President and Chief Executive Officer since January 2007... He received his B.S. in Accounting and Finance from Fairleigh Dickinson University.

Data sourced from SEC filings. Last updated: 2025-10-12